Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis--The ATTRACT Trial
The purpose of this study is to determine if the use of adjunctive Pharmacomechanical Catheter Directed Thrombolysis, which includes the intrathrombus administration of rt-PA--Activase (Alteplase),can prevent the post-thrombotic syndrome(PTS)in patients with symptomatic proximal deep vein thrombosis(DVT)as compared with optimal standard DVT therapy alone.
Stanford is now accepting new patients for this trial.
- Daniel Sze, MD, PhD
- WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FCIRSE
- Nishita Kothary, MD
- Lawrence "Rusty" Hofmann, MD
- David Hovsepian, MD
- Gloria Hwang, MD
- Caroline Berube
- John D. Louie, MD
- Donald Schreiber, MD
- drug : Recombinant tissue plasminogen activator (rt-PA)
Phase: Phase 3
Ages Eligible For Study:
- Symptomatic proximal DVT involving the iliac, common femoral, and/or femoral vein.